The main change we wish to make in participating regions and further on also in other EU regions is to provide solutions that in the long run would eliminate economic and social disparities. To achieve that goal we will make use of local strengths and provide tools strengthening support services for SMEs. The solutions and models that are going to be elaborated based on the pilot actions conducted within the project frames, will improve access to research and innovation in the field of technologies dedicated to rehabilitation.

The common challenges tackled by our project can be divided into two dimensions – social and technological.

SOCIAL CHALLENGES
On the social side the common challenge that brought all the partners together is a lack of systemic approach or models for rehabilitation of all groups of patients (seniors, patients recovering from stroke/cardiac operations, disabled children, teenagers with spinal degeneration, etc) .
The burden of care for patients often lies with the family; and the quality of care is a combination of the carer's knowledge and personal abilities, financial situation and ability to devote themselves to care. Rarely does the carer have any support. In rare cases they are supported by extended family/social care/support groups/ NGOs but that differs between countries and even regions.
Not equal access to treatment between urban / rural areas as well as depending on the economic status of the patients – social care/ public healthcare system treatment (no costs, long waiting lists)  vs private care (short terms but not affordable to all) should be solved in a systemic way through coordination of different systems and levels of governance across and within countries.
This lack of systematic rehabilitation results in significant expenditures on a national level – e.g. the estimated cost of inappropriate lifestyle and the lack of rehabilitation often neglected after treatments can even reach up to 20 % of domestic GDP (which is the case in Hungary). Adding the ageing society factor to this picture we come up with a clear and urgent need for common solutions on an European level.
And here we enter a second sphere of challenges tackled by RehAllianCE -  technological.

TECHNOLOGICAL CHALLENGES
Europe’s Rehabilitation Robots market is expected to reach US$ 708.87 million by 2028 from 185.69 US$ million in 2021. And this is only one branch of the MedTech solutions and devices supporting rehabilitation. We also have to consider other assistive devices, exoskeletons,  applications and online solutions, wearables and telemetric tools.
The market is driven by rising instances of strokes, injuries, and neurological diseases, growth in outpatient rehabilitation, and technological innovations. E.g. treatments using rehabilitation robots enable delegating more manual and repetitive therapy components to robotic devices. It allows clinician practitioners to take care of more patients in a given time. It also improves accessibility of therapy for patients who can use it remotely from homes through telerehabilitation. Moreover, additional advantages of this solution is that data collected can objectively assess performance and document progress using artificial intelligence (AI). Even though according to McKinsey Global Institute - by 2040, new technologies such as robotics and exoskeletons could reduce the total disease burden by 6 to 10 per cent, there are still issues to be solved in rehabilitation robots and many questions to be answered, such as efficacy, costs, reimbursement, and regulatory challenges. Especially in the EU, where the 4th industrial revolution reaches its full speed, together with the focus on the green and digitised economy  - common solutions for the manufacturing industry are a major challenge that require transition towards advanced technologies and digitally skilled workforce.

To tackle those challenges within our project, different innovation actors across countries (BSO, University, Digital Innovation Hubs, Regional Authorities…) join their efforts, share experience and best practices to work on the strategy and policy recommendations to improve innovation governance.
without sharing experiences in a transnational approach, reaching the objectives and results will not be possible.

Main focus will be put on enabling SMEs not only to take up innovative methods and technologies but also to work out financing models, encouraging and supporting transnational cooperation. To provide SMEs with systemic support and improve R&I potential, cooperation between  areas with different levels of research and innovation capabilities (such as the representation of Project partners and Associated Partners) is crucial.

The main change we wish to make in participating regions and further on also in other EU regions is to provide solutions that in the long run would eliminate economic and social disparities. To achieve that goal we will make use of local strengths and provide tools strengthening support services for SMEs. The solutions and models that are going to be elaborated based on the pilot actions conducted within the project frames, will improve access to research and innovation in the field of technologies dedicated to rehabilitation.

The common challenges tackled by our project can be divided into two dimensions – social and technological.

SOCIAL CHALLENGES
On the social side the common challenge that brought all the partners together is a lack of systemic approach or models for rehabilitation of all groups of patients (seniors, patients recovering from stroke/cardiac operations, disabled children, teenagers with spinal degeneration, etc) .
The burden of care for patients often lies with the family; and the quality of care is a combination of the carer's knowledge and personal abilities, financial situation and ability to devote themselves to care. Rarely does the carer have any support. In rare cases they are supported by extended family/social care/support groups/ NGOs but that differs between countries and even regions.
Not equal access to treatment between urban / rural areas as well as depending on the economic status of the patients – social care/ public healthcare system treatment (no costs, long waiting lists)  vs private care (short terms but not affordable to all) should be solved in a systemic way through coordination of different systems and levels of governance across and within countries.
This lack of systematic rehabilitation results in significant expenditures on a national level – e.g. the estimated cost of inappropriate lifestyle and the lack of rehabilitation often neglected after treatments can even reach up to 20 % of domestic GDP (which is the case in Hungary). Adding the ageing society factor to this picture we come up with a clear and urgent need for common solutions on an European level.
And here we enter a second sphere of challenges tackled by RehAllianCE -  technological.

TECHNOLOGICAL CHALLENGES
Europe’s Rehabilitation Robots market is expected to reach US$ 708.87 million by 2028 from 185.69 US$ million in 2021. And this is only one branch of the MedTech solutions and devices supporting rehabilitation. We also have to consider other assistive devices, exoskeletons,  applications and online solutions, wearables and telemetric tools.
The market is driven by rising instances of strokes, injuries, and neurological diseases, growth in outpatient rehabilitation, and technological innovations. E.g. treatments using rehabilitation robots enable delegating more manual and repetitive therapy components to robotic devices. It allows clinician practitioners to take care of more patients in a given time. It also improves accessibility of therapy for patients who can use it remotely from homes through telerehabilitation. Moreover, additional advantages of this solution is that data collected can objectively assess performance and document progress using artificial intelligence (AI). Even though according to McKinsey Global Institute - by 2040, new technologies such as robotics and exoskeletons could reduce the total disease burden by 6 to 10 per cent, there are still issues to be solved in rehabilitation robots and many questions to be answered, such as efficacy, costs, reimbursement, and regulatory challenges. Especially in the EU, where the 4th industrial revolution reaches its full speed, together with the focus on the green and digitised economy  - common solutions for the manufacturing industry are a major challenge that require transition towards advanced technologies and digitally skilled workforce.

To tackle those challenges within our project, different innovation actors across countries (BSO, University, Digital Innovation Hubs, Regional Authorities…) join their efforts, share experience and best practices to work on the strategy and policy recommendations to improve innovation governance.
without sharing experiences in a transnational approach, reaching the objectives and results will not be possible.

Main focus will be put on enabling SMEs not only to take up innovative methods and technologies but also to work out financing models, encouraging and supporting transnational cooperation. To provide SMEs with systemic support and improve R&I potential, cooperation between  areas with different levels of research and innovation capabilities (such as the representation of Project partners and Associated Partners) is crucial.

The main change we wish to make in participating regions and further on also in other EU regions is to provide solutions that in the long run would eliminate economic and social disparities. To achieve that goal we will make use of local strengths and provide tools strengthening support services for SMEs. The solutions and models that are going to be elaborated based on the pilot actions conducted within the project frames, will improve access to research and innovation in the field of technologies dedicated to rehabilitation.

The common challenges tackled by our project can be divided into two dimensions – social and technological.

SOCIAL CHALLENGES
On the social side the common challenge that brought all the partners together is a lack of systemic approach or models for rehabilitation of all groups of patients (seniors, patients recovering from stroke/cardiac operations, disabled children, teenagers with spinal degeneration, etc) .
The burden of care for patients often lies with the family; and the quality of care is a combination of the carer's knowledge and personal abilities, financial situation and ability to devote themselves to care. Rarely does the carer have any support. In rare cases they are supported by extended family/social care/support groups/ NGOs but that differs between countries and even regions.
Not equal access to treatment between urban / rural areas as well as depending on the economic status of the patients – social care/ public healthcare system treatment (no costs, long waiting lists)  vs private care (short terms but not affordable to all) should be solved in a systemic way through coordination of different systems and levels of governance across and within countries.
This lack of systematic rehabilitation results in significant expenditures on a national level – e.g. the estimated cost of inappropriate lifestyle and the lack of rehabilitation often neglected after treatments can even reach up to 20 % of domestic GDP (which is the case in Hungary). Adding the ageing society factor to this picture we come up with a clear and urgent need for common solutions on an European level.
And here we enter a second sphere of challenges tackled by RehAllianCE -  technological.

TECHNOLOGICAL CHALLENGES
Europe’s Rehabilitation Robots market is expected to reach US$ 708.87 million by 2028 from 185.69 US$ million in 2021. And this is only one branch of the MedTech solutions and devices supporting rehabilitation. We also have to consider other assistive devices, exoskeletons,  applications and online solutions, wearables and telemetric tools.
The market is driven by rising instances of strokes, injuries, and neurological diseases, growth in outpatient rehabilitation, and technological innovations. E.g. treatments using rehabilitation robots enable delegating more manual and repetitive therapy components to robotic devices. It allows clinician practitioners to take care of more patients in a given time. It also improves accessibility of therapy for patients who can use it remotely from homes through telerehabilitation. Moreover, additional advantages of this solution is that data collected can objectively assess performance and document progress using artificial intelligence (AI). Even though according to McKinsey Global Institute - by 2040, new technologies such as robotics and exoskeletons could reduce the total disease burden by 6 to 10 per cent, there are still issues to be solved in rehabilitation robots and many questions to be answered, such as efficacy, costs, reimbursement, and regulatory challenges. Especially in the EU, where the 4th industrial revolution reaches its full speed, together with the focus on the green and digitised economy  - common solutions for the manufacturing industry are a major challenge that require transition towards advanced technologies and digitally skilled workforce.

To tackle those challenges within our project, different innovation actors across countries (BSO, University, Digital Innovation Hubs, Regional Authorities…) join their efforts, share experience and best practices to work on the strategy and policy recommendations to improve innovation governance.
without sharing experiences in a transnational approach, reaching the objectives and results will not be possible.

Main focus will be put on enabling SMEs not only to take up innovative methods and technologies but also to work out financing models, encouraging and supporting transnational cooperation. To provide SMEs with systemic support and improve R&I potential, cooperation between  areas with different levels of research and innovation capabilities (such as the representation of Project partners and Associated Partners) is crucial.